ADVM - Adverum Biotechnologies - Stock Forecast

Healthcare - Sector
Coverage Stock analysts Price Targets & Ratings Chart Insider Trading

ADVM is currently covered by 5 analysts with an average price target of $-4.55. This is a potential upside of $-7.57 (-250.66%) from yesterday's end of day stock price of $3.02.

Adverum Biotechnologies's activity chart (see below) currently has 24 price targets and 52 ratings on display. The stock rating distribution of ADVM is 76.19% BUY and 23.81% HOLD.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 68.3% with an average time for these price targets to be met of 398.08 days.

Highest price target for ADVM is $33, Lowest price target is $4, average price target is $19.75.

Most recent stock forecast was given by DANIIL GATAULIN from CHARDAN CAPITAL on 13-Aug-2025. First documented stock forecast 16-Jun-2015.

Currently out of the existing stock ratings of ADVM, 16 are a BUY (76.19%), 5 are a HOLD (23.81%).

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date

Price targets met ratio

Average potential upside

Average Time (Days) For PT To Be Met

Performance score

Buy

$33

$29.48 (837.50%)

$33

30 days ago
(13-Aug-2025)

3/8 (37.5%)

$30.34 (1140.60%)

884

Buy

$12

$8.48 (240.91%)

$16

2 months 17 days ago
(26-Jun-2025)

1/4 (25%)

$9.51 (381.93%)

292

Hold

$4

$0.48 (13.64%)

$5

3 months 28 days ago
(15-May-2025)

1/5 (20%)

$1.95 (95.12%)

81

Buy

$30

$26.48 (752.27%)

$30

3 months 28 days ago
(15-May-2025)

0/6 (0%)

$27.95 (1363.41%)

Buy

$6

$4.05 (207.69%)

$4

2 years 8 days ago
(05-Sep-2023)

4/7 (57.14%)

$4.22 (237.08%)

196

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

What is ADVM (Adverum Biotechnologies) average time for price targets to be met?

On average it took 398.08 days on average for the stock forecasts to be realized with a an average price target met ratio 68.3

Which analyst has the current highest performing score on ADVM (Adverum Biotechnologies) with a proven track record?

CHARLES DUNCAN

Which analyst has the most public recommendations on ADVM (Adverum Biotechnologies)?

Charles Duncan works at CANTOR FITZGERALD and has 12 price targets and 8 ratings on ADVM

Which analyst is the currently most bullish on ADVM (Adverum Biotechnologies)?

Biren Amin with highest potential upside - $47.48

Which analyst is the currently most reserved on ADVM (Adverum Biotechnologies)?

Tyler Van Buren with lowest potential downside - -$0

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?